Deutsche Bank cuts Argenx to 'hold' on valuation

argenx SE

12/09/2025 09:48

** Deutsche Bank downgrades Belgian immunology company Argenx ARGX.BR to "hold" from "buy" on valuation grounds after the stock rallied over 40% in two months

** The downgrade follows the stock reaching the brokerage's PT, which it keeps unchanged at 655 euros ($768.18) having raised it August

** Out of 19 analysts that cover the stock, 18 rate it "strong buy" or "buy,"​ one analyst rates it "hold" - LSEG data

($1 = 0.8527 euros)

 (Reporting by Jérôme Terroy)

 ((jerome.terroy@thomsonreuters.com))